cd /news/artificial-intelligence/what-big-pharma-s-q2-results-tell-us · home › topics › artificial-intelligence › article
[ARTICLE · art-108750] src=realclearhealth.com ↗ pub= topic=artificial-intelligence verified=true sentiment=· neutral

What Big Pharma's Q2 Results Tell Us

Big Pharma's second-quarter earnings calls highlighted the growing role of AI in drug development and the intensifying oral GLP-1 competition between Novo Nordisk and Eli Lilly, alongside leadership changes at Sarepta and Sanofi, reflecting an industry at a pivotal moment of opportunity and challenge.

read1 min views1 publishedAug 24, 2026
What Big Pharma's Q2 Results Tell Us
Image: Realclearhealth (auto-discovered)

Earnings calls are a chance to catch up with the latest developments across Big Pharma and beyond, and last quarter was no different. From the rollout of AI to the oral GLP-1 battle between Novo Nordisk and Eli Lilly and new leadership at Sarepta and Sanofi, it feels like the opportunities and challenges for biopharma have never been greater.

source & further reading
realclearhealth.com — original article AI in Drug R&D: At Last, the End of the Beginning What AI Really Adds to Personal Health Data When the Denominator Disappears: FDA's Next Evolution Should Be Causal Inference
── more in #artificial-intelligence 4 stories · sorted by recency
── more on @novo nordisk 3 stories trending now
sponsored brought to you by zahid.host 4,200+ EU-deployed projects
reading about agents? ship yours in a single git push.

Run your AI side-project on zahid.host

EU-based hosting, git-push deploys, automatic HTTPS, no cold starts. Free tier with a custom domain — perfect for shipping the agent you just read about.

$git push zahid main
→ Live at https://your-agent.zahid.host ✓
Get free account → Pricing
from €0/mo · no card required
LIVE [news/what-big-pharma-s-q2…] indexed:0 read:1min 2026-08-24 · —